Table 1.
Antimicrobial susceptibility patterns of S. aureus isolates
| Antibiotics | MRSA (n = 36) | MSSA (n = 40) | Total (n = 76) |
|---|---|---|---|
| Penicillin | 0 (0%) | 2 (5%) | 2 (2.6%) |
| Cefoxitin | 0 (0%) | 40 (100%) | 40 (52.6%) |
| Ciprofloxacin | 8 (22.2%) | 13 (32.5%) | 21 (27.6%) |
| Cotrimoxazole | 10 (27.8%) | 18 (45%) | 28 (36.8%) |
| Gentamicin | 22 (61.2%) | 30 (75%) | 52 (68.4%) |
| Chloramphenicol | 35 (97.2%) | 37 (92.5%) | 72 (94.7%) |
| Erythromycin | 10 (27.8%) | 24 (60%) | 34 (44.7%) |
| Clindamycin | 32 (88.9%) | 36 (90%) | 68 (89.5%) |
| Tetracycline | 35 (97.2%) | 40 (100%) | 75 (98.7%) |
| Vancomycin | 36 (100%) | 40 (100%) | 76 (100%) |
| Linezolid | 36 (100%) | 40 (100%) | 76 (100%) |